Chapter 1. LAMEA Market
1.1 Market Overview
1.2 Key Factors Impacting Market
1.2.1 Market Drivers
1.2.2 Market Restraints
1.2.3 Market Opportunities
1.2.4 Market Challenges
1.2.5 Market Trends
1.2.6 State of Competition
1.2.7 Market Consolidation
1.2.8 Key Customer Criteria
1.3 Product Life Cycle
1.4 Segmentation By Component
1.4.1 Software
1.4.2 Services
1.5 Segmentation By Deployment Model
1.5.1 Cloud-Based
1.5.2 On-Premise
1.6 Segmentation By End User
1.6.1 Providers
1.6.2 Payers
1.7 Segmentation By Application
1.7.1 Quality Improvement and Clinical Benchmarking
1.7.2 Clinical Decision Support
1.7.3 Regulatory Reporting and Compliance
1.7.4 Comparative Effectiveness Analytics
1.7.5 Precision / Population Health
1.8 Segmentation By Country
1.8.1 Brazil
1.8.1.1 Segmentation By Component
1.8.1.1.1 Software
1.8.1.1.2 Services
1.8.1.2 Segmentation By Deployment Model
1.8.1.2.1 Cloud-Based
1.8.1.2.2 On-Premise
1.8.1.3 Segmentation By End-User
1.8.1.3.1 Providers
1.8.1.3.2 Payers
1.8.1.4 Segmentation By Application
1.8.1.4.1 Quality Improvement and Clinical Benchmarking
1.8.1.4.2 Clinical Decision Support
1.8.1.4.3 Regulatory Reporting and Compliance
1.8.1.4.4 Comparative Effectiveness Analytics
1.8.1.4.5 Precision / Population Health
1.8.2 Argentina
1.8.2.1 Segmentation By Component
1.8.2.1.1 Software
1.8.2.1.2 Services
1.8.2.2 Segmentation By Deployment Model
1.8.2.2.1 Cloud-Based
1.8.2.2.2 On-Premise
1.8.2.3 Segmentation By End-User
1.8.2.3.1 Providers
1.8.2.3.2 Payers
1.8.2.4 Segmentation By Application
1.8.2.4.1 Quality Improvement and Clinical Benchmarking
1.8.2.4.2 Clinical Decision Support
1.8.2.4.3 Regulatory Reporting and Compliance
1.8.2.4.4 Comparative Effectiveness Analytics
1.8.2.4.5 Precision / Population Health
1.8.3 UAE
1.8.3.1 Segmentation By Component
1.8.3.1.1 Software
1.8.3.1.2 Services
1.8.3.2 Segmentation By Deployment Model
1.8.3.2.1 Cloud-Based
1.8.3.2.2 On-Premise
1.8.3.3 Segmentation By End-User
1.8.3.3.1 Providers
1.8.3.3.2 Payers
1.8.3.4 Segmentation By Application
1.8.3.4.1 Quality Improvement and Clinical Benchmarking
1.8.3.4.2 Clinical Decision Support
1.8.3.4.3 Regulatory Reporting and Compliance
1.8.3.4.4 Comparative Effectiveness Analytics
1.8.3.4.5 Precision / Population Health
1.8.4 Saudi Arabia
1.8.4.1 Segmentation By Component
1.8.4.1.1 Software
1.8.4.1.2 Services
1.8.4.2 Segmentation By Deployment Model
1.8.4.2.1 Cloud-Based
1.8.4.2.2 On-Premise
1.8.4.3 Segmentation By End-User
1.8.4.3.1 Providers
1.8.4.3.2 Payers
1.8.4.4 Segmentation By Application
1.8.4.4.1 Quality Improvement and Clinical Benchmarking
1.8.4.4.2 Clinical Decision Support
1.8.4.4.3 Regulatory Reporting and Compliance
1.8.4.4.4 Comparative Effectiveness Analytics
1.8.4.4.5 Precision / Population Health
1.8.5 South Africa
1.8.5.1 Segmentation By Component
1.8.5.1.1 Software
1.8.5.1.2 Services
1.8.5.2 Segmentation By Deployment Model
1.8.5.2.1 Cloud-Based
1.8.5.2.2 On-Premise
1.8.5.3 Segmentation By End-User
1.8.5.3.1 Providers
1.8.5.3.2 Payers
1.8.5.4 Segmentation By Application
1.8.5.4.1 Quality Improvement and Clinical Benchmarking
1.8.5.4.2 Clinical Decision Support
1.8.5.4.3 Regulatory Reporting and Compliance
1.8.5.4.4 Comparative Effectiveness Analytics
1.8.5.4.5 Precision / Population Health
1.8.6 Nigeria
1.8.6.1 Segmentation By Component
1.8.6.1.1 Software
1.8.6.1.2 Services
1.8.6.2 Segmentation By Deployment Model
1.8.6.2.1 Cloud-Based
1.8.6.2.2 On-Premise
1.8.6.3 Segmentation By End-User
1.8.6.3.1 Providers
1.8.6.3.2 Payers
1.8.6.4 Segmentation By Application
1.8.6.4.1 Quality Improvement and Clinical Benchmarking
1.8.6.4.2 Clinical Decision Support
1.8.6.4.3 Regulatory Reporting and Compliance
1.8.6.4.4 Comparative Effectiveness Analytics
1.8.6.4.5 Precision / Population Health
1.8.7 Rest of LAMEA
1.8.7.1 Segmentation By Component
1.8.7.1.1 Software
1.8.7.1.2 Services
1.8.7.2 Segmentation By Deployment Model
1.8.7.2.1 Cloud-Based
1.8.7.2.2 On-Premise
1.8.7.3 Segmentation By End-User
1.8.7.3.1 Providers
1.8.7.3.2 Payers
1.8.7.4 Segmentation By Application
1.8.7.4.1 Quality Improvement and Clinical Benchmarking
1.8.7.4.2 Clinical Decision Support
1.8.7.4.3 Regulatory Reporting and Compliance
1.8.7.4.4 Comparative Effectiveness Analytics
1.8.7.4.5 Precision / Population Health
Chapter 2. Company Snapsot
2.1 IBM Corporation
2.1.1 Business Overview
2.1.2 Key Information
2.1.3 Company Focus
2.1.4 Strategic Insights
2.1.5 Strategy Deployed
2.1.6 Product & Service Portfolio
2.1.7 Capability Overview
2.1.8 Technology & Innovation Focus
2.1.9 Customers / End Users
2.1.10 Competitive Positioning
2.1.11 Key Differentiators
2.1.12 Portfolio Matrix
2.1.13 SWOT Analysis
2.1.14 Future Outlook
2.2 Oracle Corporation
2.2.1 Business Overview
2.2.2 Key Information
2.2.3 Company Focus
2.2.4 Strategic Insights
2.2.5 Strategy Deployed
2.2.6 Product & Service Portfolio
2.2.7 Capability Overview
2.2.8 Technology & Innovation Focus
2.2.9 Customers / End Users
2.2.10 Competitive Positioning
2.2.11 Key Differentiators
2.2.12 Portfolio Matrix
2.2.13 SWOT Analysis
2.2.14 Future Outlook
2.3 SAS Institute Inc.
2.3.1 Business Overview
2.3.2 Key Information
2.3.3 Company Focus
2.3.4 Strategic Insights
2.3.5 Strategy Deployed
2.3.6 Product & Service Portfolio
2.3.7 Capability Overview
2.3.8 Technology & Innovation Focus
2.3.9 Customers / End Users
2.3.10 Competitive Positioning
2.3.11 Key Differentiators
2.3.12 Portfolio Matrix
2.3.13 SWOT Analysis
2.3.14 Future Outlook
2.4 Inspirata, Inc.
2.4.1 Business Overview
2.4.2 Key Information
2.4.3 Company Focus
2.4.4 Strategic Insights
2.4.5 Strategy Deployed
2.4.6 Product & Service Portfolio
2.4.7 Capability Overview
2.4.8 Technology & Innovation Focus
2.4.9 Customers / End Users
2.4.10 Competitive Positioning
2.4.11 Key Differentiators
2.4.12 Portfolio Matrix
2.4.13 SWOT Analysis
2.4.14 Future Outlook
2.5 Allscripts Healthcare Solutions, Inc.
2.5.1 Business Overview
2.5.2 Key Information
2.5.3 Company Focus
2.5.4 Strategic Insights
2.5.5 Strategy Deployed
2.5.6 Product & Service Portfolio
2.5.7 Capability Overview
2.5.8 Technology & Innovation Focus
2.5.9 Customers / End Users
2.5.10 Competitive Positioning
2.5.11 Key Differentiators
2.5.12 Portfolio Matrix
2.5.13 SWOT Analysis
2.5.14 Future Outlook
2.6 IQVIA Holdings, Inc.
2.6.1 Business Overview
2.6.2 Key Information
2.6.3 Company Focus
2.6.4 Strategic Insights
2.6.5 Strategy Deployed
2.6.6 Product & Service Portfolio
2.6.7 Capability Overview
2.6.8 Technology & Innovation Focus
2.6.9 Customers / End Users
2.6.10 Competitive Positioning
2.6.11 Key Differentiators
2.6.12 Portfolio Matrix
2.6.13 SWOT Analysis
2.6.14 Future Outlook
2.7 Epic Systems Corporation
2.7.1 Business Overview
2.7.2 Key Information
2.7.3 Company Focus
2.7.4 Strategic Insights
2.7.5 Strategy Deployed
2.7.6 Product & Service Portfolio
2.7.7 Capability Overview
2.7.8 Technology & Innovation Focus
2.7.9 Customers / End Users
2.7.10 Competitive Positioning
2.7.11 Key Differentiators
2.7.12 Portfolio Matrix
2.7.13 SWOT Analysis
2.7.14 Future Outlook
2.8 McKesson Corporation
2.8.1 Business Overview
2.8.2 Key Information
2.8.3 Company Focus
2.8.4 Strategic Insights
2.8.5 Strategy Deployed
2.8.6 Product & Service Portfolio
2.8.7 Capability Overview
2.8.8 Technology & Innovation Focus
2.8.9 Customers / End Users
2.8.10 Competitive Positioning
2.8.11 Key Differentiators
2.8.12 Portfolio Matrix
2.8.13 SWOT Analysis
2.8.14 Future Outlook
2.9 Health Catalyst, Inc.
2.9.1 Business Overview
2.9.2 Key Information
2.9.3 Company Focus
2.9.4 Strategic Insights
2.9.5 Strategy Deployed
2.9.6 Product & Service Portfolio
2.9.7 Capability Overview
2.9.8 Technology & Innovation Focus
2.9.9 Customers / End Users
2.9.10 Competitive Positioning
2.9.11 Key Differentiators
2.9.12 Portfolio Matrix
2.9.13 SWOT Analysis
2.9.14 Future Outlook
2.10 Palantir Technologies Inc.
2.10.1 Business Overview
2.10.2 Key Information
2.10.3 Company Focus
2.10.4 Strategic Insights
2.10.5 Strategy Deployed
2.10.6 Product & Service Portfolio
2.10.7 Capability Overview
2.10.8 Technology & Innovation Focus
2.10.9 Customers / End Users
2.10.10 Competitive Positioning
2.10.11 Key Differentiators
2.10.12 Portfolio Matrix
2.10.13 SWOT Analysis
2.10.14 Future Outlook
Unique Offerings 
